Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds industry ...

By capitalizing on its advantages for business of all sizes, Wisconsin is seeing significant growth in legacy and emerging ...

A recent award ceremony which is actually significant revealed about the best companies right now existing in the country US ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Some people make it a New Year's resolution to improve their finances by investing in stocks. It's a laudable goal, and to get started, it's crucial to pick stocks that have the tools to perform well ...

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

The company has created and fostered an internal culture of innovation honed by many successes (and failures) over decades. That's what should allow Eli Lilly to continue producing billion-dollar ...

Eli Lilly is set to acquire Scorpion Therapeutics ... Samsung Biologics disclosed a contract manufacturing deal with an EU-based pharmaceutical company. Mediar Therapeutics is teaming up with Lilly on ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Both companies could launch their first GLP-1 products as early as 2028, potentially making them strong competitors to current market leaders, Novo Nordisk and Eli Lilly. All That Glitters Is Not ...